SSY Gets Production, Registration Go-Ahead for Extracellular Fluid Supplement Drug

MT Newswires Live
2025/01/03

SSY Group (HKG:2005) obtained approval to produce and register its sodium acetate Ringer's and glucose injection from China's National Medical Products Administration after it passed the latter's consistency evaluation, a Thursday Hong Kong bourse filing said.

Sodium acetate Ringer's and glucose injection is mainly used in the supplement of extracellular fluid and the correction of metabolic acidosis when circulating blood volume and interstitial fluid are reduced, as well as in supplying energy.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10